Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-02 Sale | 2024-02-06 8:18 pm | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 12,628 | $1.1354 | $14,338 | 402,891 (Direct) | View |
| 2023-02-02 Sale | 2023-02-06 5:40 pm | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 5,389 | $1.6601 | $8,946 | 196,519 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-30 Option Award | 2024-09-04 8:33 pm | N/A 2030-02-06 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-02-28 Option Award | 2024-03-01 7:16 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 141,000 | $0 | 141,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 9:16 pm | N/A 2034-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 366,000 | $0 | 572,519 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 9:45 pm | N/A 2032-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 238,000 | $0 | 426,908 (Direct) | View |
| 2022-12-28 Option Award | 2022-12-30 4:30 pm | N/A 2032-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 4:15 pm | N/A 2029-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 81,250 | $0 | 81,250 (Direct) | View |
| 2022-01-24 Option Award | 2022-01-26 8:47 pm | N/A 2032-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer | 150,000 | $0 | 228,908 (Direct) | View |
| 2021-11-04 Option Award | 2021-11-05 7:06 pm | N/A 2029-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 81,250 | $0 | 81,250 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 6:23 pm | N/A 2030-02-06 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-01-27 Option Award | 2021-01-29 6:55 pm | N/A 2031-01-27 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer | 112,500 | $0 | 112,500 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 6:16 pm | N/A 2030-02-06 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |